Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential fluconazole-induced carbamazepine toxicity.

D R Nair1, H H Morris

  • 1Department of Epilepsy, Cleveland Clinic Foundation, OH 44195, USA. naird@cesmtp.ccf.org

The Annals of Pharmacotherapy
|August 31, 1999
PubMed
Summary

Fluconazole can cause carbamazepine toxicity by inhibiting the cytochrome P450 3A4 isoenzyme. This drug interaction led to a patient experiencing stupor, which resolved after discontinuing fluconazole.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sudden cardiac death and diabetes mellitus.

Journal of diabetes and its complications·2014
Same author

QRisk superior in diverse South Asian groups--response to Robson et al.

International journal of clinical practice·2012
Same author

Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study.

International journal of clinical practice·2011
Same author

Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.

International journal of clinical practice·2011
Same author

Treatment of empyema by aspiration and chemotherapy.

Chinese medical journal (Peking, China : 1932)·2010
Same author

Epidermal inclusion cyst of the styloid process: a case report.

Skull base : official journal of North American Skull Base Society ... [et al.]·2009

Area of Science:

  • Pharmacology
  • Clinical Toxicology

Background:

  • Carbamazepine is an anticonvulsant medication with a narrow therapeutic index.
  • Drug interactions are a significant concern in managing patients on carbamazepine therapy.

Observation:

  • A 33-year-old male patient developed carbamazepine toxicity, presenting as stupor, after initiating fluconazole treatment.
  • The patient had stable carbamazepine levels prior to fluconazole initiation.
  • Discontinuation of both medications and subsequent reintroduction of carbamazepine alone led to resolution of toxicity and no further adverse events.

Findings:

  • Carbamazepine is primarily metabolized by the cytochrome P450 3A4 (CYP3A4) isoenzyme.
  • Fluconazole is known to inhibit CYP3A4 activity.
  • This inhibition likely led to decreased carbamazepine metabolism and subsequent toxicity.

Implications:

  • Clinicians should be aware of the potential for fluconazole to increase carbamazepine levels.
  • Monitoring carbamazepine concentrations is crucial when co-administering with CYP3A4 inhibitors like fluconazole.
  • This interaction highlights the importance of considering drug metabolism pathways when prescribing multiple medications.

Related Experiment Videos